Business News

The "2022–2023 Most Influential List Release of the Chinese Pharmaceutical Industry and the 15th China Pharmaceutical Industry Development Summit Forum," organized by the National Federation of Industry and Commerce Pharmaceutical Chamber, opened grandly in Harbin, Heilongjiang, from July 3-5.

During this meeting, the “2022-2023 Most Influential List in the Chinese Pharmaceutical Industry” was officially released. Haisco Medicine Group won four awards: “Top 100 Pharmaceutical Enterprises”, “Top 100 Pharmaceutical Manufacturing Enterprises”, “Pioneer of Independent Innovation Enterprises” and “Law-abiding and Honest Enterprises”!

In the future, Hisicor Pharmaceutical Group will continue to strengthen its brand advantages, enhance its industry influence, accelerate innovation and research efforts, and promote the high-quality development of China's pharmaceutical industry.